Cardiac Risk Panel
- $2,356.46
- $697.95
- Save: 70.38%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: ApoE Genotype, ApoE Genotype Cardio IQ, Apolipoprotein E Genotype, Cardio IQ ApoE Genotype
Apoe Genotype
Guidance Statements
Method
Reviewer
LP PLA2 ACTIVITY
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
Also known as: Methylenetetrahydrofolate Reductase MTHFR DNA Mutation Analysis, MTHFR
Methylenetetrahydrofolate
RESULT
Also known as: Anti-Myeloperoxidase, Churg-Strauss Syndrome, Crescentic Glomeruloephritis, MPO, Myeloperoxidase Antibody MPO
Myeloperoxidase Antibody
ARACHIDONIC ACID
ARACHIDONIC ACID/EPA
DHA
DPA
EPA
EPA+DPA+DHA
LINOLEIC ACID
OMEGA-3 TOTAL
OMEGA-6 TOTAL
OMEGA-6/OMEGA-3 RATIO
Also known as: BNP, N-terminal pro b-type natriuretic peptide, proBNP Nterminal
Probnp, N Terminal
The Cardiac Risk Panel panel contains 7 tests with 20 biomarkers .
The Cardiac Risk Panel:
The Cardiac Risk Panel provides a comprehensive assessment designed to provide you with valuable insights into your cardiovascular health and potential risks.
By analyzing a range of markers, including genetic factors, inflammation indicators, lipid metabolism, and cardiac stress markers, this panel offers a personalized approach to understanding your unique cardiac risk profile.
With the information provided by the Cardiac Risk Panel, you can take proactive steps to manage your cardiovascular health, make informed lifestyle choices, and work closely with healthcare professionals to reduce your risk of cardiovascular disease.
- CARDIO IQ™ LP PLA2 Activity: LP PLA2 (Lipoprotein-associated phospholipase A2) is an enzyme involved in the inflammatory process within blood vessels. Measuring LP PLA2 activity through the CARDIO IQ™ test can help assess the risk of plaque buildup and inflammation in the arteries, which are significant contributors to cardiovascular disease.
- Lipoprotein (A): Lipoprotein (a) is a type of lipoprotein-associated with an increased risk of cardiovascular disease. Measuring the level of lipoprotein (a) in the blood can provide insights into your potential risk for developing heart-related conditions.
- Methylenetetrahydrofolate Reductase (MTHFR), DNA Mutation Analysis: The MTHFR gene encodes an enzyme involved in folate metabolism. DNA mutation analysis of the MTHFR gene can identify specific variants, such as C677T and A1298C, which may impact the efficiency of the MTHFR enzyme. These variants have been associated with altered folate metabolism and potential health implications.
- Myeloperoxidase Antibody (MPO): Myeloperoxidase is an enzyme produced by white blood cells that plays a role in the development and progression of atherosclerosis. Measuring the levels of myeloperoxidase antibodies can help assess inflammation and oxidative stress in the arteries, providing insights into cardiovascular risk.
- Omega-3 and -6 Fatty Acids, Plasma: Omega-3 and -6 fatty acids are essential fats that play a crucial role in cardiovascular health. Measuring the levels of these fatty acids in plasma can provide insights into your dietary intake and balance of these beneficial fats, which can influence cardiovascular risk factors.
- proBNP, N-terminal: ProBNP (N-terminal pro-brain natriuretic peptide) is a marker used to assess heart function and detect the presence of heart failure. Measuring proBNP levels can help evaluate cardiac stress and identify potential cardiac abnormalities.
The Cardiac Risk Panel offers a comprehensive evaluation of your cardiovascular health, providing you with valuable information about your genetic predispositions, inflammation markers, lipid metabolism, and cardiac stress indicators.
By understanding your unique cardiac risk profile, you can take proactive measures to mitigate potential risks and optimize your cardiovascular well-being.
Armed with this knowledge, you can make informed decisions about lifestyle modifications, collaborate closely with healthcare professionals, and embrace a proactive approach to heart health. Remember, early detection, personalized interventions, and ongoing management are key to maintaining a healthy heart and reducing the likelihood of cardiovascular disease. Take charge of your cardiovascular health today with the insights provided by the Cardiac Risk Panel.